US Patent 10266592 Drug regulated transgene expression
Patent 10266592 was granted and assigned to Seattle Children's on April, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 8, 2015
0
Date of Patent
April 23, 2019
0
Patent Applicant
Patent Application Number
15302415
0
Patent Citations Received
Patent Inventor Names
Michael C. Jensen
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10266592 Drug regulated transgene expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.